跳到主要內容

Ryan Arthur F 的 Form 4 申報

Regeneron Pharmaceuticals, Inc.(REGN),2023/6/2 申報

申報編號
0001883850-23-000073
申報時間
2023/6/2
交易日
2023/6/1
申報延遲
1 天
10b5-1 計畫
有勾選

這份申報列了 9 筆非衍生性交易。公開市場賣出合計 $7.35 萬。交易後 1 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Ryan Arthur FCIK 0001187443董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2023/6/1Common StockS賣出處分−2$730.03−$1,460.0618,945直接
2023/6/1Common StockS賣出處分−9$731.49F2−$6,583.4118,936直接
2023/6/1Common StockS賣出處分−10$732.49F3−$7,324.918,926直接
2023/6/1Common StockS賣出處分−2$733.61−$1,467.2218,924直接
2023/6/1Common StockS賣出處分−10$734.62F4−$7,346.218,914直接
2023/6/1Common StockS賣出處分−12$735.42F5−$8,825.0418,902直接
2023/6/1Common StockS賣出處分−31$736.40F6−$22,828.418,871直接
2023/6/1Common StockS賣出處分−17$737.52F7−$12,537.8418,854直接
2023/6/1Common StockS賣出處分−7$738.35F8−$5,168.4518,847直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

Represents volume-weighted average price of sales of 9 shares of Company stock on June 1, 2023 at prices ranging from $731.23 to $731.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 1, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F3

Represents volume-weighted average price of sales of 10 shares of Company stock on June 1, 2023 at prices ranging from $732.10 to $732.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 1, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F4

Represents volume-weighted average price of sales of 10 shares of Company stock on June 1, 2023 at prices ranging from $734.15 to $734.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 1, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F5

Represents volume-weighted average price of sales of 12 shares of Company stock on June 1, 2023 at prices ranging from $735.00 to $735.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 1, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F6

Represents volume-weighted average price of sales of 31 shares of Company stock on June 1, 2023 at prices ranging from $736.00 to $736.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 1, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F7

Represents volume-weighted average price of sales of 17 shares of Company stock on June 1, 2023 at prices ranging from $737.00 to $737.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 1, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F8

Represents volume-weighted average price of sales of 7 shares of Company stock on June 1, 2023 at prices ranging from $738.13 to $738.67. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 1, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)